105 related articles for article (PubMed ID: 6228938)
1. [Dihydroergotoxine mesylate in the treatment of senile cerebral insufficiency. Result of a long-term multicenter double-blind clinical trial with a placebo].
Lazzari R; Passeri M; Chierichetti SM
Presse Med; 1983 Dec; 12(48):3179-85. PubMed ID: 6228938
[TBL] [Abstract][Full Text] [Related]
2. [The use of Ergocomb in symptoms of cerebrovascular insufficiency].
Pöthig D; Sauer I; Hansen H; Weidnitzer M
Z Alternsforsch; 1983; 38(6):443-9. PubMed ID: 6659572
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
Biel ML; Seus R; Struppler A
Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
[TBL] [Abstract][Full Text] [Related]
5. [Methodology of a controlled trial of dihydroergotoxine in acquired intellectual impairment in the adult].
Dartigues JF; Père JJ
Presse Med; 1983 Dec; 12(48):3173-5. PubMed ID: 6228936
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
[TBL] [Abstract][Full Text] [Related]
7. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
8. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
9. [Dihydroergotoxine mesylate in chronic cerebrovascular insufficiency: spectral EEG analysis and neuropsychological correlates].
Moglia A; Bono G; Sinforiani E; Alfonsi E; Zandrini C; Pistarini C; Arrigo A; Franch F
Farmaco Prat; 1983 Feb; 38(2):97-102. PubMed ID: 6832350
[No Abstract] [Full Text] [Related]
10. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
11. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
Jansen W; Bruckner GW; Jansen P
J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
[TBL] [Abstract][Full Text] [Related]
12. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
Dennler HJ; Bachmann H
MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
[TBL] [Abstract][Full Text] [Related]
13. A multidimensional approach to the assessment of clinical validity in a study on CCVD treatment: dihydroergocristine versus placebo.
Fioravanti M; Buckley AE; Agnoli A
Arch Gerontol Geriatr; 1987 Apr; 6(1):83-93. PubMed ID: 3109340
[TBL] [Abstract][Full Text] [Related]
14. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
15. A single blind comparison of dihydroergotoxine mesilate and clonidine for treatment of hypertensive emergencies.
Guffanti E; Vaccarella A; Meregalli M; Fiorella G; Chierichetti SM; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):506-9. PubMed ID: 3902677
[TBL] [Abstract][Full Text] [Related]
16. [A multicenter trial of treatment with slow-release dihydroergotoxine in chronic senile cerebral insufficiency].
Franchi F; Di Ruvo R; Guggino G; Mazzanti A; Genga A; Cucinotta D
G Clin Med; 1982 Jul; 63(7):465-81. PubMed ID: 6757035
[No Abstract] [Full Text] [Related]
17. [Controlled study of the effect of dihydroergocristine on organic brain psychosyndrome].
Aranda B; Dumoulin P; Groothold G
Arzneimittelforschung; 1992 Nov; 42(11A):1406-9. PubMed ID: 1492863
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of intermittent claudication: a comparative double-blind study of suloctidil, dihydroergotoxine and placebo.
Adriaensen H
Curr Med Res Opin; 1976; 4(6):395-401. PubMed ID: 793778
[TBL] [Abstract][Full Text] [Related]
19. On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies.
Saletu B; Grünberger J; Anderer R
Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):510-24. PubMed ID: 2086492
[TBL] [Abstract][Full Text] [Related]
20. [Parallel double-blind clinical trial of nifedipine versus a placebo in patients with chronic cerebrovascular insufficiency].
Vintró Molins C; Viaplana Más JM
Med Clin (Barc); 1985 Mar; 84(8):308-11. PubMed ID: 3884927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
